Latest News

Is Novavax Finally Turning Things Around?

Vaccine developer Novavax Inc. (NASDAQ: NVAX) stock shot up 28% following its Q1 2023 earnings report. The company specializes in vaccines for infectious disea

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News